Nuvectis Pharma Cash Flow Statement (2021-2026) | NVCT

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -5.94M-4.67M-5.74M-3.93M-7.28M-8.64M-15.27M-15.85M-9.70M-18.15M-21.11M-13.81M-5.03M-4.75M-25.78M-7.14M-7.34M-7.96M-8.35M-7.14M
Share-based Compensation (Quarter) 0.90M0.90M0.18M0.16M0.30M0.30M0.48M1.40M0.40M0.50M1.22M1.30M0.70M1.16M1.14M1.37M6.00M0.90M1.48M8.50M
Cash from Operations (Quarter) -4.43M-1.07M-3.08M-2.54M-4.42M-3.52M-4.78M-4.08M-3.24M-3.85M-4.36M-3.02M-2.40M-2.46M-4.17M-3.37M-4.49M-3.97M-6.51M
Change in Working Capital
Change in Account Payables (Quarter) -0.81M-0.29M1.69M-0.72M-1.01M0.09M0.41M0.24M0.49M1.99M1.46M-0.17M-1.58M
Change in Accured Expenses (Quarter) 0.36M0.11M1.10M0.54M0.26M1.45M-0.30M-0.70M0.15M0.26M0.26M0.07M-0.26M0.16M0.45M0.03M-0.86M0.06M2.13M-0.46M
Financing Activities
Other financing activities (Quarter) 1.57M0.14M16.00M0.51M0.56M0.70M10.48M0.01M
Change in Capital Stock
Shares Issued (Quarter) 0.05M0.23M0.30M0.34M0.34M0.35M0.02M0.21M0.35M1.17M0.35M0.35M0.35M0.33M0.35M0.35M0.35M0.35M
Net Equity Issued and Repurchased (Quarter) 4.02M1.13M0.90M4.85M1.70M1.50M3.95M1.27M0.60M13.50M0.17M0.01M
Misc.
Cash from Financing Activities (Quarter) 4.02M14.03M-0.58M14.49M-0.13M0.25M13.21M0.70M0.92M4.70M1.67M1.46M3.83M15.51M0.30M13.14M0.17M0.01M
Change in Cash (Quarter) -0.41M-1.07M10.95M-3.12M10.07M-3.65M-4.53M9.13M-2.54M-2.93M0.34M-1.35M-0.95M1.36M11.33M-3.07M8.65M-3.81M-6.50M
Free Cash Flow (Quarter) -4.43M-1.07M-3.08M-2.54M-4.42M-3.52M-4.78M-4.08M-3.24M-3.85M-4.36M-3.02M-2.40M-2.46M-4.17M-3.37M-4.49M-3.97M-6.51M
Net Cash Flow (Quarter) -0.41M-1.07M10.95M-3.12M10.07M-3.65M-4.53M9.13M-2.54M-2.93M0.34M-1.35M-0.95M1.36M11.33M-3.07M8.65M-3.81M-6.50M